← 홈

위암

143개 · ADC 1068 · Antibody 5456 · CGT 2744 · 다음 갱신 D-13 · 마지막 7월 13일

인기최근 업데이트큐레이션임상 많은갱신 필요ORR최신Phase 3FDA승인프로그램 143개
ADCSHOTFDACuratedFDABiologicDaiichi SankyoDXd (topo-I inhibitor)Approved

trastuzumab deruxtecan (Enhertu, T-DXd, DS-8201)

HER2+ breast cancer, HER2-low, gastric · HER2

#HER2#ADC#Approved#FDA승인#바이오모아추천+5
효능 ORR 79.7%임상시험 215상태 APPROVED
ADCSHOTFDACuratedFDABiologicRemeGenMMAEApproved

disitamab vedotin (Disitamab Vedotin, RC48)

HER2+ urothelial, gastric, breast · HER2

#HER2#ADC#Approved#FDA승인#바이오모아추천+5
효능 ORR 50%임상시험 146상태 ACTIVE
AntibodyCHotRochederuxtecan plus fluoropyrim…Phase 2

trastuzumab (Herceptin, FLOT, 5-FU, leucovorin, docetaxel, oxaliplatin, 5-FU, leucovorin, docetaxel, oxaliplatin (FLOT), trastuzumab)

Adenocarcinoma of the Gastroesophageal Junction; Adenocarcinoma of the Stomach · Adenocarcinoma of the Gastroesophageal J

#AdenocarcinomaoftheGastroesophag#Antibody#Phase2#인기#항체+5
효능 ORR 61%임상시험 100상태 ACTIVE
AntibodyCPENG YUANPhase 2

QL1706 (Iparomlimab and Tuvonralimab, Iparomlimab and Tuvonralimab (QL1706))

Platinum Resistant Ovarian Cancer; Platinum Refractory Epithelial Ovarian Cancer · Gastric Cancer (GC)

#GastricCancerGC#Antibody#Phase2#인기#항체+5
임상시험 97상태 RECRUITING
ADCABiologicAstraZenecaPhase 2

5-FU (Fluorouracil, Fluorouracil (5-FU))

Gastric Cancer · Gastric Cancer

#GastricCancer#ADC#Phase2#인기#항체약물접합체+2
효능 ORR 63.5%임상시험 93상태 RECRUITING
AntibodyCJunshi Biosciencesvedotin (EV) in combination…Phase 3

Toripalimab (Toripalimab)

Metastatic Colorectal Cancer; Liver Metastases · Gastric Cancer

#GastricCancer#Antibody#Phase3#인기#항체+5
임상시험 93상태 RECRUITING
ADCABiologicDaiichi Sankyoderuxtecan (Dato-DXd, Datro…Phase 2

trastuzumab deruxtecan (Enhertu, T-DXd, DS-8201, Trastuzumab Deruxtecan (T-DXd) monotherapy)

Gastric Adenocarcinoma; Gastroesophageal Junction Adenocarcinoma · Gastric Adenocarcinoma

#GastricAdenocarcinoma#ADC#Phase2#인기#항체약물접합체+5
효능 ORR 79.7%임상시험 91상태 RECRUITING
AntibodyCEli Lilly and CompanyDeruxtecan]Phase 3

Ramucirumab (Ramucirumab)

Advanced Esophageal Adenocarcinoma; Advanced Gastric Adenocarcinoma · Non-Small Cell Lung Cancer

#Non-SmallCellLungCancer#Antibody#Phase3#인기#항체+5
효능 ORR 40%임상시험 86상태 RECRUITING
ADCBBiologicSuzhou Transcenta Therapeutics …Govitecan in Untreated, Adv…Phase 2

Albumin-bound paclitaxel (Albumin-bound paclitaxel)

Advanced Cancer; Gastric Cancer · Solid Cancer

#SolidCancer#ADC#Phase2#인기#항체약물접합체+5
효능 ORR 63.5%임상시험 75상태 RECRUITING
ADCBiologicRemeGenvedotin plus PD-1 blockade …Phase 2

disitamab vedotin (Disitamab Vedotin, RC48, Disitamab Vedotin(RC48) Plus Tratuzumab)

HER2-positive Gastric Cancer; HER2-positive Gastroesophageal Junction Adenocarcinoma · HER2

#HER2#ADC#Phase2#인기#항체약물접합체+5
임상시험 66상태 RECRUITING
ADCBiologicMerck Sharp & Dohme LLCvedotin combined with pembr…Phase 2

Immune Checkpoint Inhibitor (Immune Checkpoint Inhibitor)

Unspecified Adult Solid Tumor, Protocol Specific · Gastric Cancer

#GastricCancer#ADC#Phase2#인기#항체약물접합체+5
효능 ORR 59%임상시험 66상태 RECRUITING
AntibodyElevation OncologyDeruxtecan]Phase 1

CYRAMZA® (Ramucirumab, Ramucirumab (CYRAMZA®))

Stomach Neoplasm; Gastrointestinal Neoplasms · Stomach Neoplasm

#StomachNeoplasm#Antibody#Phase1#인기#항체+5
효능 ORR 44.7%임상시험 66상태 DISCONTINUED
AntibodyRochePhase 3

atezolizumab (Tecentriq, Atezolizumab + Bevacizumab)

Venous Thrombosis · Gastric Adenocarcinoma

#GastricAdenocarcinoma#Antibody#Phase3#인기#항체+5
효능 ORR 49.3%임상시험 63상태 RECRUITING
CGTBiologicBeijing Geekgene Technology Co.…Preclinical

TCR-T cells (TCR-T cells)

Gastric Cancer; Esophageal Cancer · Colorectal Cancer

#ColorectalCancer#CGT#Preclinical#인기#세포유전치료+5
효능 ORR 50%임상시험 63상태 RECRUITING
ADCBiologicAstellas Pharma Global Developm…Phase 3

TAS-102 (TAS-102)

Metastatic Colorectal Cancer · Gastric Cancer

#GastricCancer#ADC#Phase3#인기#항체약물접합체+3
효능 ORR 20%임상시험 61상태 ACTIVE
AntibodyGlaxoSmithKlinederuxtecan improved objecti…Phase 2

Dostarlimab (Dostarlimab)

Neoplasms · Stomach Neoplasm

#StomachNeoplasm#Antibody#Phase2#인기#항체+5
효능 ORR 88%임상시험 60상태 DISCONTINUED
ADCBiologicGruppo Oncologico del Nord-OvestPhase 3

l-leucovorin (l-leucovorin)

Metastatic Colorectal Cancer · Gastric Cancer

#GastricCancer#ADC#Phase3#인기#항체약물접합체+3
효능 ORR 36.6%임상시험 60상태 ACTIVE
ADCBiologicGenentech, Inc.Preclinical

Anti-angiogenic drug (Anti-angiogenic drug)

Gastric Cancer; Second-line Treatment · Gastric Cancer

#GastricCancer#ADC#Preclinical#인기#항체약물접합체+3
효능 ORR 96%임상시험 59상태 RECRUITING
ADCBiologicRemeGen Co., Ltd.sPhase 2

disitamab vedotin (Disitamab Vedotin, RC48)

Non-Muscle Invasive Bladder Cancer; HER2 · Gastric Cancer/Gastroesophageal Junction

#GastricCancerGastroesophagealJun#ADC#Phase2#인기#항체약물접합체+5
임상시험 56상태 RECRUITING
ADCBiologicAstraZenecaderuxtecan plus fluoropyrim…Phase 3

FLOT Chemotherapy (FLOT Chemotherapy)

Gastrointestinal Neoplasms; Esophagogastric Junction · Gastroesophageal Adenocarcinoma

#GastroesophagealAdenocarcinoma#ADC#Phase3#인기#항체약물접합체+5
임상시험 50상태 RECRUITING

1 / 8 페이지

← 이전다음 →